+Compare
EDAP
Stock ticker:
NASDAQ
AS OF
Jul 1 closing price
Price
$6.60
Change
-$0.20 (-2.94%)
Capitalization
220.88M

EDAP Price Prediction, EDAP TMS SA AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

EDAP in downward trend: 10-day moving average moved below 50-day moving average on June 13, 2022

The 10-day moving average for EDAP crossed bearishly below the 50-day moving average on June 13, 2022. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where EDAP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

EDAP moved below its 50-day moving average on June 01, 2022 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDAP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EDAP entered a downward trend on June 24, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 28, 2022. You may want to consider a long position or call options on EDAP as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EDAP just turned positive on June 24, 2022. Looking at past instances where EDAP's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDAP advanced for three days, in of 235 cases, the price rose further within the following month. The odds of a continued upward trend are .

EDAP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EDAP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.165) is normal, around the industry mean (6.885). EDAP has a moderately high P/E Ratio (344.828) as compared to the industry average of (92.096). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.201). Dividend Yield (0.000) settles around the average of (0.022) among similar stocks. P/S Ratio (4.505) is also within normal values, averaging (79.458).

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

EDAP is expected to report earnings to fall 387.00% to -2 cents per share on August 31

EDAP TMS SA EDAP Stock Earnings Reports
Q2'22
Est.
$-0.03
Q1'22
Beat
by $0.04
Q4'21
Beat
by $0.03
Q3'21
Missed
by $0.02
Q2'21
Est.
$-0.01
The last earnings report on May 17 showed earnings per share of 0 cents, beating the estimate of -2 cents. With 10.20K shares outstanding, the current market capitalization sits at 220.88M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Edwards Lifesciences Corp (NYSE:EW), Boston Scientific Corp (NYSE:BSX), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 5.74B. The market cap for tickers in the group ranges from 775 to 3.72T. MKYSF holds the highest valuation in this group at 3.72T. The lowest valued company is BIIO at 775.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -1%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -26%. HTGM experienced the highest price growth at 98%, while ABMT experienced the biggest fall at -77%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -68%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 71
Price Growth Rating: 71
SMR Rating: 67
Profit Risk Rating: 84
Seasonality Score: -3 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a developer of minimally invasive medical devices for urological diseases

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Parc d'Activites La Poudrette-Lamartine
Phone
+33 472153150
Employees
227
Web
https://www.edap-tms.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUAMX8.370.16
+1.95%
BlackRock US Impact Investor A
CHDVX14.980.14
+0.94%
Cullen High Dividend Equity I
FITRX13.820.09
+0.66%
Delaware Total Return A
TYWSX11.070.03
+0.27%
AMG GW&K Emerging Wealth Equity I
JSEAX15.58N/A
N/A
JPMorgan International Equity A

EDAP and

Correlation & Price change

A.I.dvisor tells us that EDAP and SIEN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDAP and SIEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDAP
1D Price
Change %
EDAP100%
-2.94%
SIEN - EDAP
25%
Poorly correlated
+0.27%
SENS - EDAP
25%
Poorly correlated
-0.97%
ISR - EDAP
24%
Poorly correlated
-5.83%
DCTH - EDAP
23%
Poorly correlated
-2.26%
SINT - EDAP
22%
Poorly correlated
-2.91%
More